“…Accumulating evidence indicates that κ-CGNs, especially their low-MW degradation products, induce inflammation in the colon, resulting in a range of diseases in cell and animal models, including thrombosis [28][29][30][31], peritonitis [26,[32][33][34], paw edema [35,36], pleurisy [37,38], gastroenterocolitis [39,40], arthritis [41,42], and inflammatory bowel disease. However, CGNs also show positive health effects, such as antitumor [43], antimicrobial [44], and antiviral [45,46].…”